Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Immunoscore Is Prognostic in Low-Risk and High-Risk Stage III Colon Carcinomas Treated With Adjuvant Infusional Fluorouracil, Leucovorin, and Oxaliplatin in a Phase III Trial.
Journal: JCO precision oncology
Published: August 11, 2022
Contribution of Immunoscore and Molecular Features to Survival Prediction in Stage III Colon Cancer.
Contribution of Immunoscore and Molecular Features to Survival Prediction in Stage III Colon Cancer.
Journal: JNCI cancer spectrum
Published: October 21, 2019
Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients: NCCTG N0147 (Alliance).
Journal: Pharmacogenetics and genomics
Published: December 15, 2015
Alcohol consumption and colon cancer prognosis among participants in north central cancer treatment group phase III trial N0147.
Journal: International journal of cancer
Published: November 16, 2015
Comparison of FOLFIRI with or without cetuximab in patients with resected stage III colon cancer; NCCTG (Alliance) intergroup trial N0147.
Journal: Clinical colorectal cancer
Published: August 21, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026